By  on November 28, 2018

StriVectin has pulled back to move forward.

The L Catterton-backed business has been undergoing a turnaround under chief executive officer Joan Malloy since 2016. When she came in, the business was overdistributed, with too many stockkeeping units. And while the previous team had focused on running the brand’s hero ingredient, NIA 114 — a patented form of niacin and Vitamin B3 that is meant to strengthen the skin barrier and help other ingredients perform better — through the product line, the sku count simply got too big. 

To continue reading this article...

To Read the Full Article
SUBSCRIBE NOW

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus